DHMC tests drug derived from cannabis for rare form of epilepsy

A New Hampshire family is hopeful that a drug derived from cannabis that is being tested at Dartmouth-Hitchcock Medical Center will help treat a rare form of epilepsy.

Colton Schools, 11, has Dravet syndrome, a form of epilepsy that has ravaged his body almost since he was born.

"If I had to describe it in one word -- horrible," said his mother, Janice Taglieri. "It started for us with Colton at a very young age. So we've been dealing with this since he was about 3 months old."

Dr. Richard Morse has been treating Colton since infancy. When Colton was 3 or 4, Morse diagnosed him with Dravet syndrome.

"The average child with Dravet syndrome is prone to prolonged convulsions. And not just with fever, but in general, status epilepticus -- a prolonged seizure state," Morse said.

Morse said there are two or three cases of Dravet syndrome in New...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.